Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the adjunctive therapy to standard
antibiotic treatment of BT086 is safe and effective of decreasing the days patients require
endotracheal ventilation due to Severe Community-Acquired Pneumonia (sCAP).